VALIDATE Annual Meeting 2024 - Agenda
0900 - 1000 Closed Network Management Board (NMB) & Scientific Advisory Board (SAB) Meeting (Invitation only)
0915 - 1000 Registration & Tea/Coffee
1000 – 1015 Welcome
Prof Helen McShane, VALIDATE Network Director, University of Oxford, UK & Prof Narisara Chantratita, Mahidol University, Thailand
1015 – 1035 VALIDATE Update
Mrs Samantha Vermaak, Co-Investigator & Executive Manager, University of Oxford, UK
Prof Narisara Chantratita, Mahidol University, Thailand
1120 – 1140 Identifying Persister Mycobacterium tuberculosis Biosignatures
Dr Nastassja Kriel, Stellenbosch University, South Africa
Dr Cristian Segura-Cerda, Centro de Investigación y Asistencia en Tecnología y Diseño de Jalisco (CIATEJ), Mexico
1200 – 1300 Lunch
Prof Mary Burtnick, University of Nevada, Reno School of Medicine, USA
1330 – 1350 Alvacc A Human In Vitro Alveolus Model to Study Aerogenic TB Vaccine Binding and Translocation
Dr Diane Lee, University of Surrey, UK
1350 – 1410 Towards a T-cell Subset that can Control Mycobacterium tuberculosis Infection
Dr Munyaradzi Musvosvi, University of Cape Town (UCT), South Africa
1410 – 1430 Evaluation of BCGΔBCG1419cESAT6-PE25SS in Immunocompetent and Immunocompromised Mouse Models of TB
Dr Ana Maria Valencia-Hernandez, James Cook University, Australia
Dr Suraj Parihar, University of Cape Town (UCT), South Africa
1500 – 1530 Afternoon Break
1530 – 1645 Your Chance to Meet Other VALIDATE Members
Attendees will get the chance to meet other VALIDATE members in this high-energy, quick-fire activity aimed at fostering community building and networking.
1645 – 1700 Day Wrap up
1700 – 1830 Drinks Reception / Poster Session (Moon Room)
1830 – 2120 Annual Meeting Dinner (Lunar Room)
0900 – 0945 Lessons Learned in BP vs NTM Research
Asst Prof Ganjana Lertmemongkolchai, Chiang Mai University, Thailand
Dr Susana Flores-Villalva, INIFAP, Mexico
Dr Thao-Thy Pham, Institute of Tropical Medicine Antwerp, Belgium
1015 - 1030 Defining the Mechanism of BCG-Priming and its Impact on Subunit Vaccine Boosting
Dr Elena Stylianou, University of Oxford, UK
1030 – 1100 “Mind the Gap” – Bridging Our Knowledge of Animal and Human Tuberculosis
Prof Michele Miller, Stellenbosch University, South Africa
1100 – 1130 Morning Break
1130 – 1145 Innovative Diagnosis for PKDL/Leprosy Project Update
Prof Mitali Chatterjee, Institute of Post-Graduate Medical Education and Research (IPGMER), India
1145 – 1205 Towards a Better TB Vaccine Understanding Improved Local Immune Control by Mucosal BCG Vaccination
Dr Paula Niewold, Leiden University Medical Center (LUMC), Netherlands
1205 – 1225 Testing a Novel, Self-adjuvanting Mucosal Vaccine Candidate for TB in the Mouse Model of Infection
Dr Andy Tran, St George’s University of London (SGUL), UK
1225 – 1245 Characterising the Cytokines Associated with Trained Innate Immunity in BCG Vaccinated Non-human Primates
Dr Laura Sibley, UK Health Security Agency (UKHSA), UK
1245 - 1345 Lunch
1530 – 1600 Therapeutics Informing Vaccine Development for Human Leishmaniasis
Dr Maria Adelaida Gomez, Centro Internacional de Entrenamiento e Investigaciones Medicas (CIDEIM), Colombia
1415 – 1430 Evaluation of Recombinant Chimeric Protein Vaccine with Adjuvant Protection Against Visceral Leishmaniasis
Dr Daniela Pagliara Lage, Federal University of Minas Gerais, Brazil
1445 - 1500 Translating protective immune signatures in the lung to peripheral biomarkers for TB
Dr Paula Niewold, Leiden University Medical Centre, Netherlands
Dr Happy Tshivhula, Stellenbosch University, South Africa
1500 – 1530 Afternoon Break
1530 – 1600 Defining Correlates of Humoral Immunity Against Inhalational Melioidosis
Prof Paul Brett, University of Nevada, USA;
1600– 1630 Planning Phase I and Phase II vaccine trials: lessons from the past 30 years of human vaccine trials
Honorary Professor Allan Saul, The Burnet Institute / University of Melbourne, Australia
1630– 1645 Wrap-up and farewell
